The U.S. Congress has voted to block the approval of genetically-modified salmon produced in part on Prince Edward Island, but the vote is not expected to stop sale of the fish.
AquaBounty, a U.S.-based company, is nearing the end of what has been a 15-year process to have its salmon approved for sale as food in the States. The salmon is engineered to grow twice as fast as normal salmon. The eggs would be produced on P.E.I., and the fish would be reared in Panama.
Last week, that process appeared to hit a snag when 10 members of the House of Representatives managed to place an amendment in a draft bill that would stop the review by the Food and Drug Administration. Aqua Bounty CEO Ron Stotish told CBC News Tuesday he’s astonished a handful of people can sidetrack a 15-year science-based review.